Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Non-Current Assets (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Non-Current Assets for 15 consecutive years, with $266201.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 55.15% year-over-year to $266201.0, compared with a TTM value of $1.7 million through Oct 2025, down 6.47%, and an annual FY2025 reading of $266201.0, down 55.15% over the prior year.
  • Non-Current Assets was $266201.0 for Q4 2025 at Pharma-Bio Serv, down from $429922.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $2.7 million in Q1 2023 and bottomed at $266201.0 in Q4 2025.
  • Average Non-Current Assets over 5 years is $807096.1, with a median of $603852.5 recorded in 2023.
  • The sharpest move saw Non-Current Assets surged 153.05% in 2023, then tumbled 82.87% in 2024.
  • Year by year, Non-Current Assets stood at $1.1 million in 2021, then tumbled by 35.64% to $707243.0 in 2022, then decreased by 29.17% to $500964.0 in 2023, then grew by 18.47% to $593477.0 in 2024, then plummeted by 55.15% to $266201.0 in 2025.
  • Business Quant data shows Non-Current Assets for PBSV at $266201.0 in Q4 2025, $429922.0 in Q3 2025, and $486136.0 in Q2 2025.